Survivin as a universal tumor antigen for novel cancer immunotherapy: functions of a killer clone.
Aqui
Nicole A
NA
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Vonderheide
Robert H
RH
D002455:Cell Division / Q000276:immunology; D002470:Cell Survival / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D051034:Inhibitor of Apoptosis Proteins; D007694:Killer Cells, Natural / Q000276:immunology*; D008869:Microtubule-Associated Proteins / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology; D000077022:Survivin
C107489:BIRC5 protein, human; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D000077022:Survivin